FDA Recall of Clonazepam due to Mislabeling

FDA recalls Clonazepam due to mislabeling, posing 'life-threatening' risks. Endo Inc. issues voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets. Labeling error could lead to significant side effects including respiratory depression.